# The therapeutic effect of exosomes in type 2 diabetes mellitus and its complications

**Authors:** Yingying Liu, Jinpeng Wang, Yunwei Sun, Yan Chen

PMC · DOI: 10.3389/fmed.2025.1735392 · Frontiers in Medicine · 2025-12-19

## TL;DR

This paper reviews how exosomes, tiny cell messengers, may help treat type 2 diabetes and its complications by regulating key biological processes.

## Contribution

The paper systematically reviews the role of exosomes in regulating T2DM and its complications through specific miRNAs and proteins.

## Key findings

- Exosomes regulate insulin signaling and inflammation in T2DM.
- Exosomes from different cell sources target key pathological processes.
- Exosomes show potential as diagnostic markers and therapeutic tools.

## Abstract

Exosomes are a type of nanoscale extracellular vesicle secreted by cells, with a diameter of approximately 30–150 nm, which carry important biological molecules such as proteins, lipids, and RNA, functioning as messengers between cells and playing a central role in cell communication. Due to their involvement in various physiological and pathological processes and their low immunogenicity and good tissue penetration, exosomes have become a research hotspot for disease diagnostic markers and drug delivery carriers. Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disorder characterized primarily by high blood sugar, whose core pathogenesis includes insulin resistance and the subsequent functional deficiency of pancreatic β-cells, which can lead to various serious complications over the long term. The review systematically elaborates on the key roles of exosomes from different cell sources in regulating T2DM and its complications, focusing on how these exosomes, through their specific microRNAs (miRNAs), proteins, and other active substances they carry, act on different key targets and thereby regulate core pathological processes such as insulin signaling pathways, inflammatory responses, cell apoptosis, fibrosis, and angiogenesis. Through the review of existing evidence, we aim to reveal the complex network of exosomes as intercellular messengers and provide a solid theoretical basis for their development as new diagnostic markers and targeted therapeutic strategies.

## Linked entities

- **Diseases:** type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** deficiency (MESH:D007153), fibrosis (MESH:D005355), metabolic disorder (MESH:D008659), inflammatory (MESH:D007249), T2DM (MESH:D003924), insulin resistance (MESH:D007333)
- **Chemicals:** blood sugar (MESH:D001786), lipids (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12757354/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12757354/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12757354/full.md

---
Source: https://tomesphere.com/paper/PMC12757354